下肢深静脉慢性静脉功能不全患者报告结局的系统评价
本研究遵循COMET框架与PRISMA指南,系统检索2018年1月至2021年1月数据库,纳入103项研究,提取1183个结局指标,涵盖22个领域。结果显示结局报告异质性大,无统一报告结局,临床结局占主导(81%),生活影响结局报告不足(5%),仅50%结局完全报告。
要点
- 深静脉慢性静脉功能不全干预研究的结局报告高度异质,无统一报告结局。
- 临床结局报告最多(81%),生活影响结局报告不足(5%)。
- 仅50%的结局在方法学与结果部分完全报告,报告一致性差。
核心结论
- 深静脉慢性静脉功能不全研究的结局报告目前呈异质性,生活影响结局报告不足,该研究为制定核心结局集(COS)提供了第一步。
研究设计与样本
- 遵循COMET框架与PRISMA指南的系统评价,方案在PROSPERO注册(CRD42021236795)。
- 检索MEDLINE、Embase、Emcare、CINAHL、Cochrane CENTRAL、Cochrane系统评价数据库及Clinicaltrials.gov,时间范围为2018年1月至2021年1月。
- 纳入涉及20名以上参与者、报告深静脉慢性静脉功能不全患者结局的临床试验和观察性研究。
主要发现
- 共纳入103项研究,提取1183个原始结局,涵盖22个领域。
- 无结局被一致报告,报告最广泛的初级通畅率出现在51篇文章中(<50%)。
- 临床结局报告为主(n=963 [81%]),治疗持久性(n=278 [23%])和临床严重程度(n=108 [9%])报告频繁。
- 生活影响结局报告相对不足(n=60 [5%])。
- 结局报告一致性差,仅50%的结局被完全报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The prevalence of lower limb chronic venous insufficiency (CVI) of the deep veins is increasing and presents a significant burden to patients and health care services. To improve the evaluation of interventions it is necessary to standardise their reporting. The aim of this study was to perform a systematic review of the outcomes of interventions delivered to people with CVI of the deep veins as part of the development of a novel core outcome set (COS). METHODS: Following the Core Outcome Measures in Effectiveness Trials (COMET) framework for COS development, a systematic review was conducted to PRISMA guidance. The protocol was preregistered on PROSPERO (CRD42021236795). MEDLINE, Embase, Emcare, CINAHL, and the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews and Clinicaltrials.gov were searched from January 2018 to January 2021. Clinical trials and observational studies involving more than 20 participants, reporting outcomes for patients with CVI of the deep veins were eligible. Outcomes were extracted verbatim, condensed into agreed outcome terms and coded into domains using standard COMET taxonomy. Outcome reporting consistency, where outcomes were fully reported throughout the methods and results of their respective articles was also assessed. RESULTS: Some 103 studies were eligible. There were 1183 verbatim outcomes extracted, spanning 22 domains. No outcome was reported unanimously, with the most widely reported outcome of primary patency featuring in 51 articles (<50%). There was a predominant focus on reporting clinical outcomes (n = 963 [81%]), with treatment durability (n = 278 [23%]) and clinical severity (n = 108 [9%]) reported frequently. Life impact outcomes were relatively under-reported (n = 60 [5%]). Outcome reporting consistency was poor, with just 50% of outcomes reported fully. CONCLUSIONS: Outcome reporting in studies of people with CVI of the deep veins is currently heterogeneous. Life impact outcomes, which likely reflect patients' priorities are under-reported. This study provides the first step in the development of a COS for people with lower limb CVI of the deep veins.
引用
- McNally EH, Rudd S, Mezes P, et al. A systematic review of reported outcomes in people with lower limb chronic venous insufficiency of the deep veins. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 37948540. doi:10.1016/j.jvsv.2022.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。